Proathlete Wealth Management
WST icon

Proathlete Wealth Management’s West Pharmaceutical WST Stock Holding History

Proathlete Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.45K Buy
12
+6
+100% +$2.12K ﹤0.01% 517
2026
Q2 		$2.15K Hold
6
– – ﹤0.01% 208
2026
Q1 		$1.5K Hold
6
– – ﹤0.01% 234
2025
Q4 		$1.65K Buy
+6
New +$1.64K ﹤0.01% 242

Other funds holding WST

ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Proathlete Wealth Management's WST Position: Q3 2026 in Review

Proathlete Wealth Management increased its West Pharmaceutical (WST) stake by 100% in Q3 2026, buying an estimated $2.12K and bringing the position to 12 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Proathlete Wealth Management first reported a position in WST in Q4 2025 and has held it in 4 quarters since. 273 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Proathlete Wealth Management held 12 shares of West Pharmaceutical worth $4.45K as of Q3 2026.
  • Proathlete Wealth Management bought 6 West Pharmaceutical shares in Q3 2026, an estimated $2.12K.
  • West Pharmaceutical made up ﹤0.01% of Proathlete Wealth Management's portfolio in Q3 2026, its #517 holding.
  • Proathlete Wealth Management first reported a position in West Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • 273 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.